Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus
Purpose: Target therapy against molecular markers of EGFR family has been recently used in the treatment protocol of several diseases.However, the role of Her-2/neu in OSCC is a matter of controversy and more studies are required to clarify the role of Her-2/neu in OSCC.We aimed to investigate the role of Her-2/neu in the process of carcinogenesis